Support HDYO

HDYO is the only organization who focus solely on supporting young people impacted by HD around the world. Will you help us?

<span class="translation_missing" title="translation missing: en.hdyo.land.loading">Loading</span>
Home Language and Accessibility What is HD? New to HD? Find Resources Research Ask for Help About HDYO News Videos Store Join Mailing List Kids Teens Young Adults Parents and Family JoHD Friends Professionals DONATE! Privacy Contact Us

Research Video Series: An Update from uniQure and PTC.

December 15, 2022

Huntington's Disease Youth Organization

HDYO has more information about HD available for young people, parents and professionals on our site:


This edition of the HDYO Research Video Series addresses two updates reported by HDBuzz for trials facilitated by uniQure and PTC.

uniQure gets the green light to resume testing HD gene therapy - Following a 3-month pause in enrollment due to concerns about side effects, uniQure shared the good news that their trial of the HD gene therapy AMT-130 will continue as planned, with new safety measures in place. Original article can be seen here: https://en.hdbuzz.net/337

Update on the PTC Therapeutics PIVOT-HD Trial - Last week, PTC Therapeutics released a statement sharing that recruitment of participants into the US arm of the PIVOT-HD trial has been paused. In this article, we will lay out exactly what is known and what this announcement means. Original article can be seen here: https://en.hdbuzz.net/336

HDYO's Research Video Series sponsored by: Sage Therapeutics, Neurocrine Biosciences, uniQure and Teva Pharmaceutical Industries Ltd.

Our content is split into different groups. Choose the group that best describes your needs for more information on HD.

Kids Teens Young Adults Parents and Family JoHD Friends Professionals